Brian D. Jellison Cancer Institute installing Edison Histotripsy System.

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy ...

This group of cancers remains a challenge to diagnose, can be rapidly progressive, and requires complex treatment and follow-up care, research suggests. Despite recent advancements in treatments for ...

Ovarian cystic neoplasms are ovarian tumors that have cyst-like qualities. They can include epithelial ovarian tumors and germ cell tumors called teratomas. Ovarian cystic neoplasms can be benign, ...

Scientists have discovered how stress helps tumors resist chemotherapy and have succeeded in blocking that signal.

Chemotherapy drugs like doxorubicin and etoposide work by snapping a cancer cell’s DNA in two. The breaks are supposed to be ...

An intraductal papillary mucinous neoplasm (IPMN) is a benign or noncancerous cyst in the ducts of the pancreas. The cysts are sometimes precancerous, which means they may lead to pancreatic cancer.

The treatment for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) with immune checkpoint inhibitors (anti-PD1) with or without chemotherapy has led to an improvement in ...

BPDCN is an aggressive type of blood cancer that originates from plasmacytoid dendritic cells (pDCs), a component of the immune system that produces type 1 interferon cytokines. These cytokines help ...

Both carcinoma and melanoma are types of cancer. Carcinoma forms in the epithelial tissues, while melanoma develops in melanocytes and is generally considered a more aggressive type. Skin cancer ...